There is accumulating evidence demonstrating that HIF-1 functions as a key regulator of the adaptation responses to hypoxia in cancer tissues. To this evidence, we add that adaptation responses to glucose-deprivation plus hypoxia are also necessary for the survival of tumor cells in the tumor microenvironment, as cancer tissues are exposed to glucose-deprivation as well as hypoxia. We found that adrenomedullin (AM), VEGF, Glut-1, Glut-3, and Hexokinase-2 among 45 hypoxia-inducible genes investigated were expressed at higher levels under glucose-deprived hypoxic conditions than under hypoxic conditions. Glucose-deprivation activated the AMPK under normoxia and hypoxia. Compound C, an inhibitor of AMPK, suppressed the expressions of AM and VEGF which had already been enhanced under glucose-deprived hypoxic conditions. SiRNAs for both AMPKα1 and AMPKα2 suppressed the expressions of AM and VEGF. HIF-1α protein level and the transcriptional activity of HIF-1 under glucose-deprived hypoxic conditions were thus found to be similar to those under hypoxic conditions. Furthermore, tumor cells in 15 out of 20 human pancreatic cancer tissue specimens were stained by anti-phospho-AMPKα antibody.
INTRODUCTION
As tumors increase in size, the cancer cells are exposed to heterogeneous microenvironments, with some regions displaying a significant lack of critical metabolites including oxygen, glucose, other nutrients and growth factors [1] [2] [3] [4] . Therefore, angiogenesis is necessary for malignant growth of solid tumor cells and its involvement has been confirmed in various clinical cancers [5] [6] [7] . Tissue hypoxic response is critical for maintaining the microenvironmental homeostasis and is sophisticatedly regulated by complex mechanisms.
Hypoxia-inducible factor-1 (HIF-1) is a central regulator of these hypoxic responses [1] [2] [3] . Once it has been activated, HIF-1 stimulates transcription of a series of genes for adaptation to hypoxia including angiogenic factors, glycolytic enzymes and glucose transporters. These responses explain very well how tumor cells survive under hypoxic conditions; however, these responses are insufficient for survival of the tumor cells in the tumor tissues, which are simultaneously exposed to glucose deprivation as well as to hypoxia.
Glucose deprivation has been reported to disrupt protein folding in the endoplasmic reticulum (ER), resulting in the activation of the unfolded protein response (UPR), which enhances cell survival by limiting accumulation of unfolded or misfolded proteins in the ER and activating the transcription of the ER-resident molecular chaperones [8] [9] [10] [11] . Glucose deprivation has also been reported to activate an AMPK pathway [12] , which enhances transcription of genes involved in lipid and glucose metabolism [13] . We have recently reported that glucose deprivation enhances the expressions of more than 60 genes including asparagines synthetase to protect the cells from apoptosis induced by glucose deprivation [14] . These reports suggest that the expressions of several genes are up-regulated under glucose-deprived conditions. We aimed to determine further whether the expressions of hypoxia-inducible genes essential for the survival of cancer cells under hypoxic conditions are up-regulated under glucose-deprived hypoxic conditions (HL conditions). As pancreatic cancers are continuously exposed to such severe conditions because of their hypovasculature as demonstrated by imaging diagnosis (15, 16) , we selected pancreatic cancer cell lines in this study. We hypothesized that pancreatic cancer cells should acquire potential adaptation machineries responding to hypoxia plus glucose-deprivation for their growth and survival and thus they over-express some hypoxia-inducible genes essential for their growth and survival also under HL conditions.
To test the above hypothesis, we sought the genes whose expressions were enhanced in HL conditions by a DNA microarray analysis of a pancreatic cancer cell line. We found that 9 out of 45 known hypoxia-inducible genes were expressed under 5 HL conditions at 2-fold higher than under normoxic normal glucose conditions (NN conditions). We then found that five out of the nine hypoxia-inducible genes were expressed at higher levels under HL conditions than under hypoxic conditions in five cancer cell lines including three pancreatic cancer cell lines. To explore the mechanisms responsible for the enhanced expressions of those genes under HL conditions, we first examined the AMPK activity and the effects of an AMPK inhibitor and AMPK siRNAs respectively, on the expression of those genes, as AMPK has been reported to be an energy sensor [12] . We next measured the HIF-1α protein levels and the transcriptional activity of HIF-1 under different conditions. Finally, we examined the expression of phosphorylated AMPK in the tumor cells of 20 human pancreatic cancer tissue specimens to explore the possible roles of phosphorylated AMPK in human pancreatic cancers.
Materials and Methods

Cell culture
HeLa (cervical cancer), HepG2 (hepatoma), BxPC3 (pancreatic cancer), PCI-43
(pancreatic cancer) and MiaPaCa2 (pancreatic cancer) were cultured in Dulbecco's modified Eagle medium (glucose 1000mg/l, Nissui Pharmaceutical Co., Ltd., Japan)
supplemented with 10% fetal bovine serum (FBS, Japan Bioserum Co., Ltd., Japan), penicillin (25U/ml) and streptomycin (25μg/ml glucose (final concentration of glucose: 50mg/dl) was used, unless otherwise specified.
The cells used for the experiments were mainly MiaPaCa2 cells, unless otherwise specified.
Antibodies and chemical reagents
Anti-HIF-1α, anti-aldolase A, and anti-actin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-adrenomedullin antibody was from Alpha Diagnostic International (San Antonio, TX). 
DNA microarray analysis:
Total RNA was extracted with the use of TRIZOL Reagent (LIFE TECHNOLOGIES, Tokyo, Japan) from the MiaPaca2 cells that had been incubated for 16 hours under glucose-deprived hypoxic conditions and normal-glucose normoxic condition. Incubation under hypoxic conditions (1 % O 2 ) was done in a hypoxic chamber gassed with 94 % N 2 and 5 % CO 2 (Wakenyaku Co. Ltd., Tokyo). The glucose concentrations were 10 mg/dl and 100 mg/dl. mRNA was purified from the total RNA with the use of a Quickprep mRNA purification kit (Amersham Pharmacia Biotech, Tokyo, Japan). The differentially expressed genes were screened by using a DNA microarray system (Hokkaido System Science, Sapporo, Japan). We defined the genes which were expressed at more than 2-fold intensity under HL conditions than under normal-glucose normoxic conditions as possible glucose-deprivation-and hypoxia-inducible genes in this study.
Real-time PCR
Total RNA was prepared by using the RNeasy® mini kit and RNase-free DNase 
Western Blotting
The cells were lysed with cell lysis buffer (Cell Signaling, Danvers, MA)
supplemented with 1mM PMSF and a protease inhibitor cocktail (Roche, Basel, Switzerland). Phosphatase inhibitor cocktails (SIGMA, St. Louis, MO) were used with the cell lysis buffer when a phospho-specific antibody was used. The samples were run on Tris-HCl or Bis-Tris gels and electro-transferred to PVDF membranes. 
Luciferase Assay
The cells were seeded in 24-well plates at 7 X 
Statistical analysis:
The statistical analysis was done by using Student's t test.
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RESULTS
Expression levels of hypoxia-inducible genes:
DNA microarray analysis demonstrated that expressions of nine (adrenomedullin (AM), VEGF, Glut-1, Glut-3, Hexokinase-2, Heme oxidase-1, Plasminogen activator inhibitor 1, Prolylhydroxylase 2, and Hexokinase-1) out of forty-five known hypoxia-inducible genes were enhanced under glucose-deprived hypoxic (HL)
conditions compared with under normal-glucose normoxic (NN) conditions (Table 2) .
We then confirmed the expressions of the nineteen genes ( were not enhanced uniformly to similar levels in all cell lines, the expressions were enhanced at least in all of the three pancreatic cancer cell lines. We showed the expression levels of aldolase A, celluloplasmin, aldolase C, carbonic anhydrase 9 and adenylate kinase as representative genes whose expressions were not enhanced under HL conditions (Fig. 1b) . The expressions of these genes were enhanced under hypoxic conditions but not further enhanced under HL conditions. We then examined the expression levels of AM protein. It was expressed at the highest levels in the cells cultured under HL conditions (Fig. 1c) , in accordance with the results obtained by real-time PCR.
To confirm the effects of glucose-deprivation on the expression levels of hypoxia-inducible genes, we examined the expression levels of AM under hypoxia and normoxia in the medium supplemented with different concentrations of glucose in MiaPaca2. Glucose-deprivation enhanced the expression of AM mRNA under hypoxia and normoxia (Fig. 1d) . We next examined the expression levels of AM at the indicated time periods after incubation under different conditions. While hypoxia alone enhanced the expression of AM mRNA already at 6 hours after incubation, glucose-deprivation in addition to hypoxia enhanced the expression of AM mRNA at 12 to 16 hours after incubation (Fig. 1e) .
Activity of AMPK under HL conditions and the effects of an inhibitor of AMPK and siRNAs for AMPKs on the expressions of AM and VEGF:
As AMPK has been reported to be an energy sensor [12] and be critical for the expression of VEGF [17] , we first examined the activity of AMPK under normoxia and hypoxia at different concentrations of glucose. Both glucose-deprivation and hypoxia increased the phosphorylation of AMPK and glucose deprivation plus hypoxia further increased the phosphorylation of AMPK (Fig. 2a) . These results are consistent with the recent report [18] . Compound C, an inhibitor of AMPK, suppressed the enhanced expressions of AM and VEGF under HL conditions but not under HN conditions (Fig.   2b ). Thereafter, we examined the effects of siRNAs for AMPKα1 and AMPKα2 on their expressions. The siRNAs for AMPKα1 and AMPKα2 efficiently suppressed the expressions of AMPKα1 and AMPKα2, respectively (Fig. 2c) . They almost completely suppressed the enhanced expressions of AM and VEGF induced under HL conditions, whereas they did not show any effect on the expression of aldolase A (Fig.   2d ). These results suggest that both AMPKα isoforms are implicated in the signal transduction pathway to enhanced expression of AM and VEGF under HL conditions.
Protein levels and transcriptional activity of HIF-1:
Although it has been reported that AMPK did not affect the HIF-1α protein expression or nuclear translocation [19] , expression levels of HIF-1α protein under HL conditions have not been demonstrated. Therefore, we examined the protein levels of HIF-1α protein under different conditions. HIF-1α protein was expressed obviously under hypoxic conditions; however, the expression was not further enhanced under HL conditions. (Fig. 3a) . Its expression was rather suppressed under HL conditions compared with that under hypoxic conditions. Furthermore, siRNAs for AMPK did not show any significant effect on the expression levels of HIF-1α protein under hypoxic conditions (Fig. 3b) . In consistent with the HIF-1α protein expression, luciferase activities increased under hypoxic conditions, but not further increased under HL conditions, when a pGL4 5xHRE-Luc vector containing hypoxia-responsive elements was used (Fig. 3c) ; however, the luciferase activities increased under hypoxic conditions and further increased under HL conditions, when a pGL3-proVEGF reporter vector was used (Fig. 3d) . Furthermore, siRNAs for AMPK suppressed the luciferase activities increased under HL conditions, when a pGL3-proVEGF reporter vector was used (Fig. 3e) . These results suggest that the enhanced expression of at least VEGF under HL conditions may not be explained by the enhanced transcription of VEGF through the activation of HIF-1α alone and that some transcription factor(s) activated by the AMPK pathway may be involved in the enhanced expression of VEGF. As recent reports have demonstrated that glucose-deprivation enhances the mRNA stability of VEGF through the activation of AMPK [20] , this mechanism may explain the enhanced expressions of AM and VEGF under HL conditions. We then examined the mRNA stability of AM, VEGF and Glut-1. The stability of mRNAs was not affected under HL conditions (Fig. 4) . The half-lives of mRNAs were found to be substantially shorter under HL conditions than those under other conditions.
Expression of activated AMPK in human pancreatic cancer tissues:
As our in vitro results suggest that AMPK is implicated in the signal transduction (Fig. 5a ). The cells near necrotic tissue were stained with anti-phospho-AMPKα antibody, but those near blood vessels were not (Fig.   5b ). These results suggested that anti-phospho-AMPKα antibody could be used for the immunohistochemical staining of phosphorylated AMPK in the tumor tissues.
Then we examined the expression of phosphorylated AMPKα in human pancreatic cancer tissue specimens. We found that 15 out of 20 pancreatic cancer tissue specimens were positive for phosphorylated AMPKα by an immunohistochemical examination. A representative pancreatic cancer tissue specimen that was positive for anti-phosphorylated-AMPKα antibody is shown in Fig. 5c .
DISCUSSION
In this study, we for the first time demonstrated that some, though not all, hypoxia-inducible genes were expressed at higher levels under HL conditions than under hypoxic conditions. Up to now, more than 60 hypoxia-inducible genes have been reported, and we know that their protein products play important roles in angiogenesis, vascular reactivity and remodeling, energy metabolism, erythropoiesis, cell proliferation, and survival [21] . Although it is unknown at this point whether the expression of every hypoxia-inducible gene is up-regulated under HL conditions, the current study led us to hypothesize that certain genes up-regulated by hypoxia plus glucose-deprivation may play more critical roles in tumor formation in vivo than other genes whose expressions are not enhanced by hypoxia plus glucose-deprivation.
We first examined the roles of AMPK in the enhancement of expressions of those genes under HL conditions, as AMPK is an energy sensor [12, 22, 23] . We herein clearly demonstrated that glucose-deprivation activated AMPK under both hypoxia and normoxia and that the blockade of AMPK activation almost completely suppressed the expressions of those genes enhanced under HL conditions, which thus suggests that AMPK contributes to the signal transduction for enhancing the expressions of those five genes under HL conditions. AMPK is a heterotrimer that contains α-, β-, and γ-subunits, each of which has at least two isoforms [12] .
Decreases in the energy state cause conformational changes in AMPK, which makes it susceptible to phosphorylation and activation by AMPK kinase. Once activated, AMPK phosphorylates several down-stream substrates, thus inducing an overall effect, including the switching off of ATP-consuming pathways that are not acutely necessary for survival, and the switching on of ATP-generating pathways such as glycolysis and fatty acid oxidation necessary for survival [12] . The relationship between AMPK and cancer remains intriguing enough to study because of numerous reasons [22] . One is that the tumor suppressor LKB1 has been identified to be an upstream activator of hours after the reporter vector (pGL3-proVEGF) and the internal control vector were transfected, and then the cells were incubated under the four different conditions.
After incubation for 24 hours, the luciferase activity was measured as described in (c).
e. The culture medium was changed 6 hours after siRNA transfection reporter vector (pGL3-proVEGF) and the internal control vector were transfected. Then the cells were incubated under NL or HL condition. The luciferase activity was measured after 24 hours incubation as described in (c). 
